MP83-04: The challenge of high risk non muscle invasive bladder cancer treatment in elderly patients (VM - 2018)

The challenge of high risk non muscle invasive bladder cancer treatment in elderly patients

View Poster

INTRODUCTION

To evaluate the efficacy and safety of a tailored endovesical immunotherapy protocol with BCG for elderly Patients with high risk non muscle invasive bladder cancer (HG-NMIBC).

METHODS

We enrolled 200 consecutive patients older than 80 years newly diagnosed with HGNMIBC: 100 (group 1) with multiple comorbidities (WHO PS 2-3, ASA score >3, Charlson Comorbidity index >3, GFR